• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2426-0007
Device Problems Insufficient Flow or Under Infusion (2182); Blocked Connection (2888)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/14/2019
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: 250 ml baxter bag, ndc 0338-0049-02, lot: y290197, exp: may 2020; 50 ml baxter bag, ndc 0338-0049-31, lot: p383174, exp: feb 2020, 0.9% sodium chloride injection; (2) curos caps.The customer¿s report that a bumex infusion had not infused was confirmed.Functional testing was performed.The disposable sets in their ¿as-received¿ state, connected in a secondary setup configuration, exhibited occlusion at the upper smartsite valve and the connection was verified to be fully secured; however reconnecting resolved the issue.The disposable sets passed rate accuracy testing performed through the upper smartsite valve as a secondary infusion after the occlusion was no longer occurring.The cause of the customer¿s experience was a failure of the smartsite valve activating and allowing fluid flow.The root cause of the smartsite failure was not determined.
 
Event Description
It was reported that a secondary bumex (0.25mg/ml 4mg/250ml) infusion was programmed at 66ml/hr.For 1 hr.The nurse noted that the bag was completely full (not administered), and the safety clamps were unclamped.It was later reported that patient required additional bumex doses which were administered without issue.The customer added that no air in line (ail) alarms were seen in the cqi data, however patient side occlusion alarms were present.Although requested, there was no further information provided.There was no report of patient harm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS® PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
stephen bilello
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key8707398
MDR Text Key148292017
Report Number9616066-2019-01433
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403227998
UDI-Public10885403227998
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2426-0007
Device Catalogue Number2426-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/11/2019
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/18/2019
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
8015,30873,72213N,8100, TD: (B)(6) 2019
Patient Outcome(s) Required Intervention;
-
-